Results of the Tokyo trial of prevention of post-ERCP pancreatitis with risperidone-2: a multicenter, randomized, placebo-controlled, double-blind clinical trial
The aim of this study was to evaluate the efficacy of risperidone alone for the prevention of PEP. We initially enrolled 500 patients in the study